Alzheimer’s disease

There are concerns that exposure to general anaesthesia during surgery may contribute to an increased risk of Alzheimer’s disease.

New findings suggest that late-onset Alzheimer’s disease is driven by epigenetic changes – how and when certain genes are turned on and off – in the brain.

Researchers reported that participants who were taking at least one anticholinergic drug were 47% more likely to develop mild cognitive impairment.

Researchers have developed an AI algorithm that promises to accurately diagnose Alzheimer’s without the need for expensive scans or in-person testing.

A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease.

Artificial intelligence (AI) could help to diagnose Alzheimer’s faster and improve patient prognosis, a new study has revealed.

Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer’s disease, according to new research.

Studies in animal models have found that increasing the aggregation of Aβ in the hippocampus, the brain’s main learning and memory centre.

The results of numerous lab investigations and population studies support the preventive potential of omega-3 fatty acids.

Forms of dementia, including Alzheimer’s disease, gradually affect your cognitive function by harming your memory.

Misfolded protein build-up in the gut could contribute to the development of Alzheimer’s-like symptoms in mice.

Researchers at Karolinska Institute have imaged tau protein in the brains of living patients with Alzheimer’s disease.

Alzheimer’s disease is the most common type of dementia and may contribute to 60–70% of cases.

Alzheimer’s disease is considered to be the most common neurodegenerative disease that is associated with ageing.

Within the UK alone 850,000 people suffer from dementia and numbers are set to rise to over 1 million by 2025.